Mineralys Therapeutics
PublicLast Round
Follow-on Offering
Sep 4, 2025
Total Funding Raised
$786.3M
Company Overview
Mineralys (NAS: MLYS) is a biopharmaceutical company focused on developing innovative treatments for diseases associated with elevated aldosterone levels, including its lead product candidate, lorundrostat, an oral selective aldosterone synthase inhibitor aimed at managing uncontrolled and resistant hypertension.
Sector
Healthcare
AI Layer
Non-AI
Keywords
oral aldosterone synthase inhibitor (ASI)uncontrolled and resistant hypertension therapyhighly selective aldosterone synthase inhibitordysregulated aldosterone disease treatmenttargeted hypertension therapycortisol-sparing hypertension drugcardiorenal condition therapyhypertension drug developmentmineralocorticoid receptor antagonist (MRA) alternativechronic kidney disease (CKD) therapyobstructive sleep apnea therapy
Mineralys Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Mineralys Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Sep 4, 2025 | ||||
| Private Placement | Feb 8, 2024 | ||||
| IPO Announced | Feb 9, 2023 | ||||
| Series B | Jun 8, 2022 | ||||
| Series A | Apr 6, 2021 |
Mineralys Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Evercore ISI | IPO, Follow-on Offering |
| HealthCor Partners Management | Series B |
| RA Capital Management | IPO, Series B, Private Placement |
| TCG Crossover | Private Placement |
| Guggenheim Securities | IPO |
| Phase4 Partners | Series B |
| Andera Partners | Series B |
Mineralys Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Firmographic Details
HeadquartersRadnor, Pennsylvania
Employee Range126
Year Founded2020
Last FundingSep 4, 2025